Lomaira: First New Appetite Suppressant in 20 Years in South Florida for 2017
Best for Evening Eating and Cravings
Lomaira is lowest dose appetite suppressor in the phentermine group. It can be taken up to three times a day before meals. Long acting phentermine has been prescribed by physicians for over 50 years. We have used Lomaira in South Florida since it was released in 2016 with great results. Unlike the higher doses of phentermine (adipex, Fastin), Lomaira can be taken before each meal and in the late afternoon or early evening. Its ideal for dieters with hunger at dinner and in the evening when the longer acting phentermine medications are naturally wearing and are less effective. Higher doses or taking them latter in the day often interferes with sleep. Because it is a “short” acting appetite suppressor its ideal for people overeating at dinner and thru the evening. Miami patients use it for the “dangerous” early evening eating cravings.
Phentermine Long Acting Group of Appetite Suppressors(Adipex and others), What to Expect
Phentermine is an appetite suppressant and is the most commonly prescribed drug for weight loss. Over 7 million prescriptions are written for phentermine yearly by a wide range of healthcare professionals (HCPs), including obesity medicine specialists, family practitioners, endocrinologists, internists and cardiologists.
Phentermine hydrochloride- long acting- is typically prescribed in doses ranging from 15, 30 or 37.5 mg (adipex) and taken at breakfast or in the mid-morning. It is effective for about 8-10 hours, gradually wearing off in the early evening. Here are the most common forms of phentermine long acting. Because of the long acting effect of phentermine only a single dose is prescribed. This results in much less phentermine in the blood after 5 pm than before 5 pm. Long acting medications are not released evenly over the day. Adipex is the only long active form that can be split into half doses. Often taken in the morning and later in the afternoon.
Lomaira: New Immediate Acting, Short Duration, Ultra Low Dose Appetite Suppressor
Lomaira new FDA approved appetite pill is a low dose, short acting appetite suppressor of the phentermine group. Instead of the extended release lasting 10-12 hours of adipex and the other long acting phentermine products, the manufacturer produced an immediate acting, short duration medication. Designed to be taken before meals and last only 4 hours, it’s action starts quickly and ends quickly. After taking Lomaria, it quickly dissolves in the stomach and then is rapidly absorbed into the blood. In minutes it passes into the brain ad effects the appetite centers by increasing neurochemicals that supress appetite and lower cravings.
The usual adult dose of Lomaira is one tablet( 8 mg) three times a day- 1/2 hour before meals. The butterfly-shaped tablet is scored to facilitate administering one half of the usual dosage for patients not requiring the full dose.
Here are the advantages of the new low dose, short acting Lomaira:
- 4 hr Appetite Control: ideal for evening hunger control with effecting sleep!
- Minimal Side Effects
- Easy to control dosing
- Long history of safety
- Minimal interference with sleep
- Possible less development of tolerance
- Inexpensive compared to new medications
- Ideal of evening over-eaters
Here are some of the disadvantages:
- Very low dose
- If used alone, need to take 2 or 3 doses a day
- May need to be combined with a second medication to achieve full day appetite control.
Dosage should be individualized to obtain an adequate response with the lowest effective dose. Phentermine is not recommended for use in pediatric patients 16 years of age or younger. For dieters needing appetite control this 4 hour pill can be taken as late as 6 pm without effecting sleep!
Questions about Lomaira:
How safe is Lomaira? (from the Lomaira Prescribing information)
“The active ingredient in Lomaira is phentermine HCl, an appetite suppressant, which has been widely-prescribed by physicians since 1959 and is currently prescribed over 7 million times a year in the United States alone. Lomaira 8 mg provides a low-dose formulation of phentermine HCI compared to the typical doses ranging from 15 to 37.5 mg. As with all medications, there are potential side effects. Some side effects of phentermine that have been reported include pulmonary hypertension, valvular heart disease, palpitations, increased heart rate or blood pressure, insomnia, restlessness, dry mouth, diarrhea, constipation and changes in sexual drive. These are not all of the potential side effects of phentermine. For the full prescribing information, visit www.lomaira.com.”
What are the active ingredients in Lomaira?
“The active ingredient in Lomaira is phentermine HCI, an FDA-approved appetite suppressant that has been widely prescribed since 1959 and is intended for short term use of up to 12 weeks.”
Are there any side effects associated with Lomaira?
“As with all medications, there are possible side effects associated with taking Lomaira. Some side effects of phentermine that have been reported include pulmonary hypertension, valvular heart disease, palpitations, increased heart rate or blood pressure, insomnia, restlessness, dry mouth, diarrhea, constipation and changes in sexual drive.
When did the FDA approve Lomaira?
Lomaira was approved by the FDA on September 12, 2016. Lomaira is available in all U.S. pharmacies.
IMPORTANT SAFETY INFORMATION
“Don’t take Lomaira™ if you have a history of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure or uncontrolled high blood pressure); are taking or have taken a monoamine oxidase inhibitor drug (MAOI) within the past 14 days; have overactive thyroid, glaucoma (increased pressure in the eyes), agitation or a history of drug abuse; are pregnant, nursing, or allergic to the sympathomimetic amines such as phentermine or any of the ingredients in Lomaira.”